AGP Executive Report
Last update: 7 hours agoBladder Cancer Treatment Update: The EU’s CHMP has issued a positive opinion for pembrolizumab (Keytruda) plus enfortumab vedotin (Padcev) as perioperative therapy for resectable muscle-invasive bladder cancer, with a decision expected in Q4 2026 for EU states including Iceland. Public Safety in Sport: Police are investigating a knife attack between two swimming coaches in Iceland; the victim was treated in an emergency department. Vitamin D Reality Check: A new report argues that taking extra vitamin D isn’t automatically beneficial, even as interest rises with shorter days. Wellness Travel Trend: Europe’s wellness tourism model—rooted in thermal water, forests and local rituals—is expanding, with investors increasingly treating wellness as a major hospitality asset. Prepared Food for Healthier Eating: Florette is rolling out a ready-to-eat “House Salad Bowl” in Iceland stores, aiming to make everyday lunches easier. Mental Health Through Movement: A Latvian man is walking around the world to support his mental health, saying a past trip to Iceland helped him feel happiest. Fish-Skin Wound Care: A US clinic is using cod-derived fish skin as a skin substitute to help a chronic scalp wound heal.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Pembrolizumab/Enfortumab Vedotin Earns Positive CHMP Opinion in MIBC]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/27123886-930626510-5eb41dddc2582afbc99f50c263359de127e4fa9c-5500x4000-100x73.jpeg)
